TNF and pyelonephritis: The most commonly reported side effects of adalimumab, as well as other TNF-α inhibitors, include sepsis due to bacterial, fungal, and viral infections, opportunistic infections, pneumonias, pyelonephritis, septic arthritis, and tuberculosis [52].